Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | B1 bradykinin receptor | ||
Ligand | BDBM50202430 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_423668 (CHEMBL913433) | ||
Ki | 62.5±n/a nM | ||
Citation | Kuduk, SD; Di Marco, CN; Chang, RK; Wood, MR; Schirripa, KM; Kim, JJ; Wai, JM; DiPardo, RM; Murphy, KL; Ransom, RW; Harrell, CM; Reiss, DR; Holahan, MA; Cook, J; Hess, JF; Sain, N; Urban, MO; Tang, C; Prueksaritanont, T; Pettibone, DJ; Bock, MG Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists. J Med Chem50:272-82 (2007) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
B1 bradykinin receptor | |||
Name: | B1 bradykinin receptor | ||
Synonyms: | B1 BRADYKININ | B1 bradykinin receptor | B1R | BDKRB1 | BK-1 receptor | BKRB1_HUMAN | BRADYB1 | Bradykinin B1 receptor | ||
Type: | Enzyme | ||
Mol. Mass.: | 40508.87 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P46663 | ||
Residue: | 353 | ||
Sequence: |
| ||
BDBM50202430 | |||
n/a | |||
Name | BDBM50202430 | ||
Synonyms: | CHEMBL220978 | N-{(1R)-1-[3,3'-difluoro-2'-(1-methyl-1H-tetraazol-5-yl)-1,1'-biphenyl-4-yl]ethyl}-1-[(trifluoroacetyl)amino]cyclopropanecarboxamide | ||
Type | Small organic molecule | ||
Emp. Form. | C22H19F5N6O2 | ||
Mol. Mass. | 494.4173 | ||
SMILES | C[C@@H](NC(=O)C1(CC1)NC(=O)C(F)(F)F)c1ccc(cc1F)-c1cccc(F)c1-c1nnnn1C |r,wU:1.0,(-6.38,-42.46,;-6.38,-40.92,;-7.71,-40.15,;-9.05,-40.92,;-9.05,-42.46,;-10.38,-40.15,;-11.17,-41.48,;-11.93,-40.14,;-10.38,-38.61,;-9.05,-37.84,;-7.71,-38.61,;-9.05,-36.31,;-9.06,-34.77,;-7.52,-36.3,;-10.58,-36.32,;-5.04,-40.14,;-5.05,-38.61,;-3.72,-37.84,;-2.38,-38.61,;-2.38,-40.15,;-3.71,-40.92,;-3.72,-42.46,;-1.05,-37.84,;.29,-38.61,;1.61,-37.84,;1.61,-36.3,;.27,-35.53,;.27,-33.99,;-1.06,-36.31,;-2.39,-35.56,;-3.77,-36.2,;-4.82,-35.08,;-4.07,-33.74,;-2.56,-34.04,;-1.43,-33,)| | ||
Structure |